← Evidence map

ArticleMolecular oncology2016

MDM2 antagonist nutlin-3a sensitizes tumors to V-ATPase inhibition.

Lina S Schneider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27157929